PortfoliosLab logoPortfoliosLab logo
CER.L vs. LLY
Performance
Return for Risk
Drawdowns
Volatility
Dividends
Financials

Performance

CER.L vs. LLY - Performance Comparison

The chart below illustrates the hypothetical performance of a £10,000 investment in Cerillion plc (CER.L) and Eli Lilly and Company (LLY). The values are adjusted to include any dividend payments, if applicable.

Loading graphics...

Different Trading Currencies

CER.L is traded in GBp, while LLY is traded in USD. To make them comparable, the LLY values have been converted to GBp using the latest available exchange rates.

Returns By Period

In the year-to-date period, CER.L achieves a 7.32% return, which is significantly higher than LLY's -11.14% return. Over the past 10 years, CER.L has underperformed LLY with an annualized return of 30.49%, while LLY has yielded a comparatively higher 32.19% annualized return.


CER.L

1D
-1.14%
1M
-7.47%
YTD
7.32%
6M
-15.26%
1Y
-13.07%
3Y*
5.89%
5Y*
23.36%
10Y*
30.49%

LLY

1D
-1.36%
1M
-5.73%
YTD
-11.14%
6M
13.90%
1Y
18.37%
3Y*
36.82%
5Y*
40.90%
10Y*
32.19%
*Multi-year figures are annualized to reflect compound growth (CAGR)

CER.L vs. LLY - Yearly Performance Comparison


2026 (YTD)202520242023202220212020201920182017
CER.L
Cerillion plc
7.32%-29.70%10.46%33.65%37.13%116.30%78.05%81.73%-4.14%8.93%
LLY
Eli Lilly and Company
-11.14%30.25%35.63%52.87%50.22%67.65%27.19%11.72%48.78%7.64%

Correlation

The correlation between CER.L and LLY is 0.04, meaning there is essentially no relationship between their price movements. They neither move together nor in opposition — each responds to its own set of market drivers. This independence makes them strong candidates for combining in a diversified portfolio.


Fundamentals

Market Cap

CER.L:

£384.47M

LLY:

$840.15B

EPS

CER.L:

£1.08

LLY:

$22.96

PE Ratio

CER.L:

12.06

LLY:

40.75

PEG Ratio

CER.L:

0.44

LLY:

0.82

PS Ratio

CER.L:

4.31

LLY:

12.90

PB Ratio

CER.L:

6.45

LLY:

31.66

Total Revenue (TTM)

CER.L:

£89.11M

LLY:

$65.18B

Gross Profit (TTM)

CER.L:

£67.58M

LLY:

$54.62B

EBITDA (TTM)

CER.L:

£46.30M

LLY:

$27.94B

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

CER.L vs. LLY — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

CER.L
CER.L Risk / Return Rank: 2828
Overall Rank
CER.L Sharpe Ratio Rank: 2727
Sharpe Ratio Rank
CER.L Sortino Ratio Rank: 2626
Sortino Ratio Rank
CER.L Omega Ratio Rank: 2626
Omega Ratio Rank
CER.L Calmar Ratio Rank: 3131
Calmar Ratio Rank
CER.L Martin Ratio Rank: 3030
Martin Ratio Rank

LLY
LLY Risk / Return Rank: 5151
Overall Rank
LLY Sharpe Ratio Rank: 5353
Sharpe Ratio Rank
LLY Sortino Ratio Rank: 4848
Sortino Ratio Rank
LLY Omega Ratio Rank: 4949
Omega Ratio Rank
LLY Calmar Ratio Rank: 5252
Calmar Ratio Rank
LLY Martin Ratio Rank: 5454
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

CER.L vs. LLY - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Cerillion plc (CER.L) and Eli Lilly and Company (LLY). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


CER.LLLYDifference

Sharpe ratio

Return per unit of total volatility

-0.29

0.31

-0.61

Sortino ratio

Return per unit of downside risk

-0.10

0.72

-0.82

Omega ratio

Gain probability vs. loss probability

0.99

1.10

-0.11

Calmar ratio

Return relative to maximum drawdown

-0.28

0.47

-0.74

Martin ratio

Return relative to average drawdown

-0.55

1.08

-1.63

CER.L vs. LLY - Sharpe Ratio Comparison

The current CER.L Sharpe Ratio is -0.29, which is lower than the LLY Sharpe Ratio of 0.31. The chart below compares the historical Sharpe Ratios of CER.L and LLY, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading graphics...

Sharpe Ratios by Period


CER.LLLYDifference

Sharpe Ratio (1Y)

Calculated over the trailing 1-year period

-0.29

0.31

-0.61

Sharpe Ratio (5Y)

Calculated over the trailing 5-year period

0.60

1.26

-0.67

Sharpe Ratio (10Y)

Calculated over the trailing 10-year period

0.86

1.04

-0.18

Sharpe Ratio (All Time)

Calculated using the full available price history

0.97

0.77

+0.20

Drawdowns

CER.L vs. LLY - Drawdown Comparison

The maximum CER.L drawdown since its inception was -47.28%, which is greater than LLY's maximum drawdown of -36.85%. Use the drawdown chart below to compare losses from any high point for CER.L and LLY.


Loading graphics...

Drawdown Indicators


CER.LLLYDifference

Max Drawdown

Largest peak-to-trough decline

-47.28%

-68.24%

+20.96%

Max Drawdown (1Y)

Largest decline over 1 year

-47.28%

-30.26%

-17.02%

Max Drawdown (5Y)

Largest decline over 5 years

-47.28%

-34.48%

-12.80%

Max Drawdown (10Y)

Largest decline over 10 years

-47.28%

-34.48%

-12.80%

Current Drawdown

Current decline from peak

-31.81%

-15.57%

-16.24%

Average Drawdown

Average peak-to-trough decline

-10.24%

-19.25%

+9.01%

Ulcer Index

Depth and duration of drawdowns from previous peaks

23.70%

12.43%

+11.27%

Volatility

CER.L vs. LLY - Volatility Comparison

Cerillion plc (CER.L) has a higher volatility of 20.61% compared to Eli Lilly and Company (LLY) at 9.75%. This indicates that CER.L's price experiences larger fluctuations and is considered to be riskier than LLY based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading graphics...

Volatility by Period


CER.LLLYDifference

Volatility (1M)

Calculated over the trailing 1-month period

20.61%

9.75%

+10.86%

Volatility (6M)

Calculated over the trailing 6-month period

33.64%

24.99%

+8.65%

Volatility (1Y)

Calculated over the trailing 1-year period

49.02%

42.62%

+6.40%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

39.15%

32.57%

+6.58%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

37.41%

30.97%

+6.44%

Dividends

CER.L vs. LLY - Dividend Comparison

CER.L's dividend yield for the trailing twelve months is around 1.18%, more than LLY's 0.67% yield.


TTM20252024202320222021202020192018201720162015
CER.L
Cerillion plc
1.18%1.15%1.28%0.70%0.75%0.80%2.12%1.92%3.15%2.73%2.82%0.00%
LLY
Eli Lilly and Company
0.67%0.56%0.67%0.78%1.07%1.23%1.75%1.96%1.94%2.46%2.77%2.37%

Financials

CER.L vs. LLY - Financials Comparison

This section allows you to compare key financial metrics between Cerillion plc and Eli Lilly and Company. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


0.005.00B10.00B15.00B20.00BAprilJulyOctober2022AprilJulyOctober2023AprilJulyOctober2024AprilJulyOctober2025AprilJulyOctober
24.44M
19.29B
(CER.L) Total Revenue
(LLY) Total Revenue
Please note, different currencies. CER.L values in GBp, LLY values in USD

CER.L vs. LLY - Profitability Comparison

The chart below illustrates the profitability comparison between Cerillion plc and Eli Lilly and Company over time, highlighting three key metrics: Gross Profit Margin, Operating Margin, and Net Profit Margin.

Gross Margin
Operating Margin
Net Margin
Quarterly
Annual

70.0%75.0%80.0%85.0%AprilJulyOctober2022AprilJulyOctober2023AprilJulyOctober2024AprilJulyOctober2025AprilJulyOctober
77.5%
85.1%
Portfolio components
CER.L - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Apr 2026, Cerillion plc reported a gross profit of 18.94M and revenue of 24.44M. Therefore, the gross margin over that period was 77.5%.

LLY - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Apr 2026, Eli Lilly and Company reported a gross profit of 16.41B and revenue of 19.29B. Therefore, the gross margin over that period was 85.1%.

CER.L - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Apr 2026, Cerillion plc reported an operating income of 11.60M and revenue of 24.44M, resulting in an operating margin of 47.5%.

LLY - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Apr 2026, Eli Lilly and Company reported an operating income of 8.78B and revenue of 19.29B, resulting in an operating margin of 45.5%.

CER.L - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Apr 2026, Cerillion plc reported a net income of 9.58M and revenue of 24.44M, resulting in a net margin of 39.2%.

LLY - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Apr 2026, Eli Lilly and Company reported a net income of 6.64B and revenue of 19.29B, resulting in a net margin of 34.4%.